Moleculin Biotech (MBRX) has provided an announcement.
Moleculin Biotech, Inc. is set to captivate investors and market watchers with a virtual AML Clinical Day on May 7, 2024, at 10:30 AM ET, as revealed in their recent press release. The event promises insights into the company’s advances and is expected to draw significant interest from the financial community.
See more insights into MBRX stock on TipRanks’ Stock Analysis page.
